journal article·2020-10

Deciphering the metabolic fates of a green fluorescent protein (GFP)-like fluorophore: Metabolite identification, isoenzyme contribution and species differences

Qing-Qing He, Yue Chen, Qi-Hang Zhou, Feng Zhang, Yi-Nan Wang, Chao-Ran Wang, Yu-Qi He, Xin-Miao Liang, Guang-Bo Ge, Ling Yang

Dyes and Pigments· Volume 181
Publisher page

Abstract

Abstract 3,5-Difluoro-4-hydroxybenzylidene imidazolinone (DFHBI), a small molecule of green fluorescent protein (GFP)-like fluorophore, has been widely used for sensing a variety of biological molecules in living systems. This study aimed to investigate the metabolic pathways and metabolic kinetics of this fluorophore in liver preparations from human and six commonly used experimental animals. Preliminary study has demonstrated that DFHBI is very stable in phase I metabolic system but this agent can be readily converted to its O-glucuronide by mammalian UDP-glucuronosyltransferases (UGTs) in the presence of UDPGA. It was also found that DFHBI-O-glucuronidation strongly reduced the fluorescence response of DFHBI, owing to that DFHBI-O-glucuronide could not form a fluorescent complex with Broccoli aptamer. Reaction phenotyping assays and chemical inhibition assays revealed that UGT1A1 played a key role in DFHBI-O-glucuronidation in the human liver, while UGT1A3, UGT1A7, UGT1A8, UGT1A9 and UGT1A10 contributed to a lesser extent. Further investigation demonstrated that DFHBI could also be O-glucuronidated by liver microsomes from all tested animal species, including human, mouse, rat, rabbit, dog, minipig and cynomolgus monkey, but the metabolic kinetics and DFHBI-O-glucuronidation rates in the liver microsomes from various species were much varied. Collectively, our findings suggested that O-glucuronidation was the major metabolic pathway of DFHBI in mammals, while UGT1A1 played a crucial role in DFHBI-O-glucuronidation in the human body. All these findings would be very helpful for deep understanding the metabolic fates of DFHBI in living systems, and also suggested that the metabolic stability of this fluorophore should be improved in future for imaging applications in living systems.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Advanced Fluorescence Microscopy Techniques · Glycosylation and Glycoproteins Research · Metabolomics and Mass Spectrometry Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (44)

Show source-provided references
1. Green fluorescent protein (GFP): applications, structure, and related photophysical behavior10.1021/cr010142r ↗
2. Development and applications of superfolder and split fluorescent protein detection systems in biology10.3390/ijms20143479 ↗
3. GFP technology for live cell imaging10.1016/j.pbi.2003.09.014 ↗
4. Design of red-shifted and environment-sensitive fluorogens based on GFP chromophore core10.1016/j.dyepig.2020.108258 ↗
5. A photoactivatable GFP for selective photolabeling of proteins and cells10.1126/science.1074952 ↗
6. Understanding the photophysics of the spinach-DFHBI RNA aptamer-fluorogen complex to improve live-cell RNA imaging10.1021/ja411060p ↗
7. A conformational switch-based fluorescent biosensor for homogeneous detection of telomerase activity10.1016/j.talanta.2019.02.018 ↗
8. A genetically encoded fluorescent biosensor for detecting nitroreductase activity in living cancer cells10.1016/j.aca.2019.08.058 ↗
9. Split spinach aptamer for highly selective recognition of DNA and RNA at ambient temperatures10.1002/cbic.201600323 ↗
10. Cascade transcription amplification of RNA aptamer for ultrasensitive MicroRNA detection10.1021/acs.analchem.9b00124 ↗
11. Live cell imaging using riboswitch-spinach tRNA fusions as metabolite-sensing fluorescent biosensors10.1007/978-1-4939-2730-2_8 ↗
12. Tandem spinach array for mRNA imaging in living bacterial cells10.1038/srep17295 ↗
13. Synthesis of new fluorogenic cyanine dyes and incorporation into RNA fluoromodules10.1021/ol702920e ↗
14. Structural basis for reversible photobleaching of a green fluorescent protein homologue10.1073/pnas.0700059104 ↗
15. Probing the decay coordinate of the green fluorescent protein: arrest of cis-trans isomerization by the protein significantly narrows the fluorescence spectra10.1021/ja0555421 ↗
16. Reversible denaturation of Aequorea green-fluorescent protein: physical separation and characterization of the renatured protein10.1021/bi00262a003 ↗
17. Radiationless relaxation in a synthetic analogue of the green fluorescent protein chromophore10.1021/jp011430u ↗
18. cybLuc: an effective aminoluciferin derivative for deep bioluminescence imaging10.1021/acs.analchem.6b03510 ↗
19. Small, long blood half-life iodine nanoparticle for vascular and tumor imaging10.1038/s41598-018-31940-2 ↗
20. Near-infrared emitting fluorophore-doped calcium phosphate nanoparticles for in vivo imaging of human breast cancer10.1021/nn800448r ↗
21. Near-infrared emitting fluorophore-doped calcium phosphate nanoparticles for in vivo imaging of human breast cancer10.1016/j.cclet.2017.09.033 ↗
22. Characterization of catechol glucuronidation in rat liver10.1124/dmd.30.2.199 ↗
23. Human CYPs involved in drug metabolism: structures, substrates and binding affinities10.1517/17425251003674380 ↗
24. UDP-glucuronosyltransferases10.2174/1389200003339171 ↗
25. RNA mimics of green fluorescent protein10.1126/science.1207339 ↗
26. Broccoli: rapid selection of an RNA mimic of green fluorescent protein by fluorescence-based selection and directed evolution10.1021/ja508478x ↗
27. Selectivity for inhibition of nilotinib on the catalytic activity of human UDP-glucuronosyltransferases10.3109/00498254.2013.840750 ↗
28. Potent and selective inhibition of magnolol on catalytic activities of UGT1A7 and 1A910.3109/00498254.2012.681814 ↗
29. Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: the effect of fluconazole on zidovudine glucuronidation10.1111/j.1365-2125.2006.02588.x ↗
30. An optimized ratiometric fluorescent probe for sensing human UDP-glucuronosyltransferase 1A1 and its biological applications10.1016/j.bios.2015.05.003 ↗
31. Identification and characterization of human UDP-glucuronosyltransferases responsible for the in-vitro glucuronidation of arctigenin10.1111/jphp.12483 ↗
32. Identification and characterization of human UDP-glucuronosyltransferases responsible for the glucuronidation of fraxetin10.2133/dmpk.DMPK-13-RG-059 ↗
33. A practical and high-affinity fluorescent probe for uridine diphosphate glucuronosyltransferase 1A1: a good surrogate for bilirubin10.1021/acs.jmedchem.7b01097 ↗
34. Identification and characterization of human UDP-glucuronosyltransferases responsible for xanthotoxol glucuronidation10.1080/00498254.2017.1283719 ↗
35. Glucuronidation of bavachinin by human tissues and expressed UGT enzymes: identification of UGT1A1 and UGT1A8 as the major contributing enzymes10.1016/j.dmpk.2015.07.001 ↗
36. A G-quadruplex-containing RNA activates fluorescence in a GFP-like fluorophore10.1038/nchembio.1561 ↗
37. Synthetic biological approaches for RNA labelling and imaging: design principles and future opportunities10.1016/j.copbio.2017.04.003 ↗
38. Targeted quantitative proteomics for the analysis of 14 UGT1As and -2Bs in human liver using NanoUPLC-MS/MS with selected reaction monitoring10.1021/pr4004213 ↗
39. Functions and transcriptional regulation of adult human hepatic UDP-glucuronosyl-transferases (UGTs): mechanisms responsible for interindividual variation of UGT levels10.1016/j.bcp.2010.04.034 ↗
40. Optimized methods for targeted peptide-based quantification of human uridine 5'-diphosphate-glucuronosyltransferases in biological specimens using liquid chromatography-tandem mass spectrometry10.1124/dmd.113.056291 ↗
41. Determination of propofol UDP-glucuronosyltransferase (UGT) activities in hepatic microsomes from different species by UFLC-ESI-MS10.1016/j.jpba.2010.07.049 ↗
42. Species differences in drug glucuronidation: humanized UDP-glucuronosyltransferase 1 mice and their application for predicting drug glucuronidation and drug-induced toxicity in humans10.1016/j.dmpk.2017.10.002 ↗
43. Species difference in glucuronidation formation kinetics with a selective mTOR inhibitor10.1124/dmd.113.054809 ↗
44. Identification and characterization of human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of daphnetin10.1124/dmd.109.030734 ↗